Friday, June 23, 2017 12:37:17 PM
Re: inesdefilia post# 65634
Post #
65642
of 73179 Go
"Relief Requested
1. The proofs of claim listed on Exhibit A annexed hereto relate in whole or
in part to securities identified by ISIN XS0282978666 or ISIN XS0301813522 (the “Preferred
Securities”) issued by Lehman Brothers UK Capital Funding IV L.P. (“LB UK IV”) or Lehman
Brothers UK Capital Funding V L.P. (“LB UK V” and, together with LB UK IV, the “Trusts”),
non-Debtor entities. LBHI issued guarantees in connection with the Preferred Securities
(together, the “Subordinated Guarantees”) which rank LBHI’s obligations, if any, junior to all
subordinated liabilities of LBHI and pari passu with LBHI’s preferred equity"
34457 02/06/2013
Order Signed on 2/6/2013 Granting Three Hundred Seventy-Ninth Omnibus Objection to Claims (Subordinated Guarantee Claims). (Related Doc # [32652]) (Nulty, Lynda)
Case: Lehman Brothers Holdings Inc.
Related: 32652
Document
32652 12/07/2012
Motion for Omnibus Objection to Claim(s) : Three Hundred Seventy-Ninth Omnibus Objection to Claims (Subordinated Guarantee Claims) filed by Robert J. Lemons on behalf of Lehman Brothers Holdings Inc.. with hearing to be held on 1/30/2013 at 10:00 AM at Courtroom 601 (JMP) Responses due by 1/9/2013, (Lemons, Robert)
Case: Lehman Brothers Holdings Inc.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM